Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kelly Van Lancker

Awards & Distinctions

11 Results

2024

Assumption-lean cox regression

Stijn VansteelandtOliver DukesKelly Van LanckerTorben Martinussen

A1 Journal Article in JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Chasing shadows : how implausible assumptions skew our understanding of causal estimands

Stijn VansteelandtKelly Van Lancker

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

2023

Ensuring valid inference for cox hazard ratios after variable selection

Kelly Van LanckerOliver DukesStijn Vansteelandt

A1 Journal Article in BIOMETRICS

PROMISE : effect of protein supplementation on fat-free mass preservation after bariatric surgery, a randomized double-blind placebo-controlled trial

A. E. TaselaarA. J. BoesR. W. F. de BruinT. M. KuijperKelly Van LanckerE. van der HarstR. A. Klaassen

A1 Journal Article in TRIALS

Single-arm studies involving patient-reported outcome data in oncology : a literature review on current practice

Limin LiuJungyeon ChoiJammbe Z. MusoroWilli SauerbreiCecilie Delphin AmdalAhu AlanyaYolanda BarbachanoJoseph C. CappelleriRagnhild Sørum FalkMallorie H. Fiero et al.

A1 Journal Article in LANCET ONCOLOGY

2021

Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trial

Kelly Van LanckerAn VandeboschStijn Vansteelandt

A1 Journal Article in BIOMETRICAL JOURNAL

On identification of the principal stratum effect in patients who would comply if treated

Oliver DukesKelly Van LanckerBjörn BornkampDominik HeinzmannKaspar RufibachMarcel Wolbers

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

Optimizing treatment effect estimation in randomized trials by leveraging baseline covariates and early read-outs

Kelly Van LanckerStijn VansteelandtAn Vandebosch

Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpoint

Kelly Van LanckerOliver DukesStijn Vansteelandt

A1 Journal Article in STATISTICS IN MEDICINE

2020

Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates

Kelly Van LanckerAn VandeboschStijn Vansteelandt

A1 Journal Article in PHARMACEUTICAL STATISTICS

2019

Evaluating futility of a binary clinical endpoint using early read‐outs

Kelly Van LanckerAn VandeboschStijn VansteelandtFilip De Ridder

A1 Journal Article in STATISTICS IN MEDICINE